522-535
NOVEL DRUG DELIVERY APPROACHES FOR COLONIC DRUG DELIVERY SYSTEM: A REVIEW
Authors: Verma Surender⃰, Goyal Gourav, Singh Gurdev

Number of views: 385
Colon related diseases is the world-wide health problem in which Colorectal cancer is the second most dangerous
type of cancer, affecting both men and women. The modern diet and lifestyles, with high meat consumption and
excessive alcohol use, along with limited physical activity has led to an increasing mortality rate for colon cancer
worldwide. As a result, there is a need to develop novel drug therapies for colon related diseases. Colon specific
drug delivery system (CDDS) has attracted significant attention during the past 20 years in providing several
therapeutic advantages particularly for drugs that are sensitive to acidic condition and to intestinal enzymes. The
colon is a site where both local and systemic delivery of drug can takes place. Oral drug delivery to treat colonic
diseases encounters many problems like drug stability in the harsh environment of upper GI tract. Sustained
colonic release of drugs can be useful in the treatment of nocturnal asthma, angina and arthritis while site
specific release strategy is needed for local action for condition involving colonic pathologies such as ulcerative
colitis, colorectal cancer and crohn’s diseases. This review is focused on primary and novel drug delivery
formulation and approaches for colonic drug delivery through pH sensitive system, microbially triggered system,
time release system, osmotically controlled drug system, pressure dependent release system, probiotic approach,
chronotropic system, Pulsincap system, prodrug approach, Enterion capsule based system, port system,
CODES™ approach, COLAL-PRED approach, multiparticulate based system.
Keywords: CDDS, Ulcerative colitis, colorectal cancer, CODES™